These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26732078)

  • 1. Anemia and transfusion in the neonate.
    Colombatti R; Sainati L; Trevisanuto D
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):2-9. PubMed ID: 26732078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical management of anemia in patients with CKD].
    Rivera RF; Alibrandi MTS; Di Lullo L; Fioccari F
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):20-35. PubMed ID: 28682026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood utilization and hemoglobin levels in cancer patients after label and coverage changes for erythropoiesis-stimulating agents.
    Xu H; Kaye JA; Saltus CW; Crawford J; Gasal E; Goodnough LT
    Expert Rev Hematol; 2014 Oct; 7(5):617-33. PubMed ID: 25081548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the development of anemia after subarachnoid hemorrhage.
    Sampson TR; Dhar R; Diringer MN
    Neurocrit Care; 2010 Feb; 12(1):4-9. PubMed ID: 19777386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decreased transfusions in preterm infants with anemia treated with erythropoietin].
    López-Catzín JF; Bolado-García PB; Gamboa-López GJ; Medina-Escobedo CE; Cambranes-Catzima LR
    Rev Med Inst Mex Seguro Soc; 2016; 54(5):576-80. PubMed ID: 27428338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for anemia, taking risks into consideration: erythropoiesis-stimulating agents versus transfusions.
    Spano JP; Khayat D
    Oncologist; 2008; 13 Suppl 3():27-32. PubMed ID: 18458122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia in the critically ill.
    Shander A
    Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on erythropoiesis-stimulating agents.
    Goodnough LT; Shander A
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):121-9. PubMed ID: 23590921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis and management of anemia in the newborn.
    Bizzarro MJ; Colson E; Ehrenkranz RA
    Pediatr Clin North Am; 2004 Aug; 51(4):1087-107, xi. PubMed ID: 15275990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.
    Gawade PL; Berlin JA; Henry DH; Tomita D; Brooks BD; Franklin J; Bradbury BD; Critchlow CW
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1357-1366. PubMed ID: 28809079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia of critical illness.
    Asare K
    Pharmacotherapy; 2008 Oct; 28(10):1267-82. PubMed ID: 18823222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
    Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P;
    Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.
    Collins AJ; Monda KL; Molony JT; Li S; Gilbertson DT; Bradbury BD
    Am J Kidney Dis; 2014 Jun; 63(6):997-1006. PubMed ID: 24315770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and treatment of preoperative anemia: Continuing Professional Development.
    Hare GM; Baker JE; Pavenski K
    Can J Anaesth; 2011 Jun; 58(6):569-81. PubMed ID: 21484608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Nutrition, Erythrocytes, and Erythropoietin in the NICU: Erythropoietic and Neuroprotective Effects.
    Kling PJ
    Neoreviews; 2020 Feb; 21(2):e80-e88. PubMed ID: 32005718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.
    Pirker R
    Expert Opin Drug Saf; 2009 Sep; 8(5):515-22. PubMed ID: 19637988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia in critical illness.
    Eckardt KU
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):84-9. PubMed ID: 11253745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia, blood loss, and blood transfusions in North American children in the intensive care unit.
    Bateman ST; Lacroix J; Boven K; Forbes P; Barton R; Thomas NJ; Jacobs B; Markovitz B; Goldstein B; Hanson JH; Li HA; Randolph AG;
    Am J Respir Crit Care Med; 2008 Jul; 178(1):26-33. PubMed ID: 18420962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis and the approach to anemia in premature infants.
    Juul S
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):97-9. PubMed ID: 23025780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.